/TCMD
TCMD Stock - Tactile Systems Technology, Inc.
Healthcare|Medical - DevicesNASDAQ
$29.95+0.27%
+$0.08 (+0.27%) • Jan 13
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).50
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.83
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+0.2%upside
Target: $30.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TCMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$29.65 – $30.25
TARGET (TP)$30.00
STOP LOSS$27.55
RISK/REWARD1:0.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.92
52W High$31.13
52W Low$8.61
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $292.98M | $274.42M | $246.78M | $208.06M | $187.13M |
| Gross Profit | $216.69M | $195.13M | $175.98M | $148.21M | $132.81M |
| Gross Margin | 74.0% | 71.1% | 71.3% | 71.2% | 71.0% |
| Operating Income | $22.18M | $18.04M | $-12,758,000 | $-1,762,000 | $-3,628,000 |
| Net Income | $16.96M | $28.52M | $-17,866,000 | $-11,811,000 | $-620,000 |
| Net Margin | 5.8% | 10.4% | -7.2% | -5.7% | -0.3% |
| EPS | $0.71 | $1.24 | $-0.89 | $-0.60 | $-0.03 |
Company Overview
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TCMDBeat Rate
78%
Last 18 quarters
Avg Surprise
+180.9%
EPS vs Estimate
Beats / Misses
14/4
Last 12 quarters
Latest EPS
$0.36
Q4 2025
EPS Surprise History
Q1 24
+84.2%
$0.35vs$0.19
Q2 24
+54.5%
$-0.05vs$-0.11
Q3 24
+50.0%
$0.18vs$0.12
Q4 24
+16.7%
$0.21vs$0.18
Q1 25
+29.0%
$0.40vs$0.31
Q2 25
-85.7%
$-0.13vs$-0.07
Q3 25
+55.6%
$0.14vs$0.09
Q4 25
+125.0%
$0.36vs$0.16
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 17, 2026 | $0.44 | — | — | — |
Q4 2025 | Nov 3, 2025 | $0.16 | $0.36 | +125.0% | ✓ BEAT |
Q3 2025 | Aug 4, 2025 | $0.09 | $0.14 | +55.6% | ✓ BEAT |
Q2 2025 | May 5, 2025 | $-0.07 | $-0.13 | -85.7% | ✗ MISS |
Q1 2025 | Feb 18, 2025 | $0.31 | $0.40 | +29.0% | ✓ BEAT |
Q4 2024 | Nov 4, 2024 | $0.18 | $0.21 | +16.7% | ✓ BEAT |
Q3 2024 | Aug 5, 2024 | $0.12 | $0.18 | +50.0% | ✓ BEAT |
Q2 2024 | May 6, 2024 | $-0.11 | $-0.05 | +54.5% | ✓ BEAT |
Q1 2024 | Feb 20, 2024 | $0.19 | $0.35 | +84.2% | ✓ BEAT |
Q4 2023 | Nov 6, 2023 | $0.04 | $0.94 | +2463.4% | ✓ BEAT |
Q3 2023 | Aug 7, 2023 | $-0.05 | $0.05 | +200.0% | ✓ BEAT |
Q2 2023 | May 8, 2023 | $-0.27 | $-0.03 | +88.9% | ✓ BEAT |
Q1 2023 | Feb 21, 2023 | $0.14 | $0.23 | +64.3% | ✓ BEAT |
Q4 2022 | Nov 7, 2022 | $-0.10 | $0.10 | +200.0% | ✓ BEAT |
Q3 2022 | Aug 1, 2022 | $-0.16 | $-0.14 | +12.5% | ✓ BEAT |
Q2 2022 | May 2, 2022 | $-0.31 | $-0.42 | -35.5% | ✗ MISS |
Q1 2022 | Feb 22, 2022 | $0.06 | $-0.28 | -566.7% | ✗ MISS |
Q4 2021 | Nov 8, 2021 | $0.13 | $-0.08 | -161.5% | ✗ MISS |
Q3 2021 | Aug 2, 2021 | $0.01 | $0.07 | +660.9% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about TCMD
What is TCMD's current stock price?
Tactile Systems Technology, Inc. (TCMD) is currently trading at $29.95 per share. The stock has moved +0.27% today.
What is the analyst price target for TCMD?
The average analyst price target for TCMD is $30.00, based on 1 analyst.
What sector is Tactile Systems Technology, Inc. in?
Tactile Systems Technology, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is TCMD's market cap?
Tactile Systems Technology, Inc. has a market capitalization of $0.67 billion, making it a small-cap company.
Does TCMD pay dividends?
No, Tactile Systems Technology, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBFLY
Butterfly Network, Inc.
$4.40
Mkt Cap: $1.1B
BWAY
BrainsWay Ltd.
$23.84
Mkt Cap: $0.5B
CBLL
CeriBell, Inc.
$22.79
Mkt Cap: $0.8B
DCTH
Delcath Systems, Inc.
$10.42
Mkt Cap: $0.4B
KIDS
OrthoPediatrics Corp.
$18.69
Mkt Cap: $0.5B
NPCE
NeuroPace, Inc.
$16.13
Mkt Cap: $0.5B
RXST
RxSight, Inc.
$10.11
Mkt Cap: $0.4B
SMLR
Semler Scientific, Inc.
$20.34
Mkt Cap: $0.3B
SRDX
Surmodics, Inc.
$42.98
Mkt Cap: $0.6B
VMD
Viemed Healthcare, Inc.
$7.25
Mkt Cap: $0.3B
Explore stocks similar to TCMD for comparison